# Rituximab Trial for Pediatric Nephrotic Syndrome

> **NCT01716442** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Seoul National University Childrens Hospital** · enrollment: 88 (estimated)

## Conditions studied

- Steroid Resistant Nephrotic Syndrome
- Steroid Dependent Nephrotic Syndrome

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01716442
- **Lead sponsor:** Seoul National University Childrens Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2013-09
- **Final completion:** 2013-11
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2012-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716442, "Rituximab Trial for Pediatric Nephrotic Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01716442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*